Skin Conditions

Cannabidiol exerts sebostatic and anti-inflammatory effects on human sebocytes
The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities
Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis
CBD exerts sebostatic and anti-inflammatory effects on human sebocytes
The endocannabinoid system of the skin in health and disease
Epigenetic control of skin differentiation genes by phytocannabinoids
A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ
Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1
Cannabinoid 1 receptors in keratinocytes modulate proinflammatory chemokine secretion and attenuate contact allergic inflammation
Attenuation of allergic contact dermatitis through the endocannabinoid system
Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus
The role of cannabinoids in dermatology
Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42/44 MAPK

What are your Feelings

Still stuck? How can we help?